Furthermore, there was a significant increase in thepercentage of CD69+ NK cells in the presence IL-2/IL15compared to the absence of exosomes in refractory/relapsed DLBCL (P=0.038), responsive DLBCL patients(P=0.0001) and healthy donors (P=0.001). The gene discussed is IL2; the disease is diffuse large B-cell lymphoma.